Loading clinical trials...
Loading clinical trials...
Phase IV Study of the Efficacy of Entecavir in Patients With Chronic Hepatitis B Virus Infection and Persistently Normal Alanine Aminotransferase
Conditions
Interventions
Entecavir
placebo
Locations
4
Taiwan
Buddhist Dalin Tzu-Chi General Hospital
Chiayi City, Taiwan
Chia-Yi Christian Hospital
Chiayi City, Taiwan
Chang-Gung Memorial Hospital, Kaohsiung
Kaohsiung City, Taiwan
Kaohsiung Medical University Hospital
Kaohsiung City, Taiwan
Start Date
September 1, 2008
Primary Completion Date
November 1, 2014
Completion Date
May 1, 2015
Last Updated
April 17, 2013
NCT06671093
NCT06885710
NCT06263959
NCT06295328
NCT02883647
NCT04139850
Lead Sponsor
National Cheng-Kung University Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions